224 related articles for article (PubMed ID: 7790462)
1. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa.
Jaffar-Bandjee MC; Lazdunski A; Bally M; Carrère J; Chazalette JP; Galabert C
J Clin Microbiol; 1995 Apr; 33(4):924-9. PubMed ID: 7790462
[TBL] [Abstract][Full Text] [Related]
2. [Production of elastase, exotoxin A and alkaline protease during bronchopulmonary exacerbations in patients with mucoviscidosis chronically infected by Pseudomonas aeruginosa].
Jaffar-Bandjee MC; Carrere J; Bally M; Chazalette JP; Galabert C
Pathol Biol (Paris); 1994 May; 42(5):505-9. PubMed ID: 7824322
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B
J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
[TBL] [Abstract][Full Text] [Related]
4. Immunoenzymometric assays for alkaline protease and exotoxin A from Pseudomonas aeruginosa: development and use in detecting exoproteins in clinical isolates from patients with cystic fibrosis.
Jaffar-Bandjee MC; Carrère J; Bally M; Guy-Crotte O; Galabert C
Eur J Clin Chem Clin Biochem; 1994 Dec; 32(12):893-9. PubMed ID: 7696436
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.
Woods DE; Schaffer MS; Rabin HR; Campbell GD; Sokol PA
J Clin Microbiol; 1986 Aug; 24(2):260-4. PubMed ID: 3018037
[TBL] [Abstract][Full Text] [Related]
6. Population transcript accumulation of Pseudomonas aeruginosa exotoxin A and elastase in sputa from patients with cystic fibrosis.
Storey DG; Ujack EE; Rabin HR
Infect Immun; 1992 Nov; 60(11):4687-94. PubMed ID: 1383155
[TBL] [Abstract][Full Text] [Related]
7. Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis.
Grimwood K; Semple RA; Rabin HR; Sokol PA; Woods DE
Pediatr Pulmonol; 1993 Mar; 15(3):135-9. PubMed ID: 8327274
[TBL] [Abstract][Full Text] [Related]
8. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis.
Granström M; Ericsson A; Strandvik B; Wretlind B; Pavlovskis OR; Berka R; Vasil ML
Acta Paediatr Scand; 1984 Nov; 73(6):772-7. PubMed ID: 6441448
[TBL] [Abstract][Full Text] [Related]
9. Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.
Pitt TL
J R Soc Med; 1986; 79 Suppl 12(Suppl 12):13-8. PubMed ID: 2425090
[No Abstract] [Full Text] [Related]
10. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.
Jagger KS; Robinson DL; Franz MN; Warren RL
J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785
[TBL] [Abstract][Full Text] [Related]
11. [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections].
Döring G
Infection; 1987; 15 Suppl 2():S38-41. PubMed ID: 3112018
[TBL] [Abstract][Full Text] [Related]
12. [Significance of Pseudomonas aeruginosa virulence factors in acute and chronic Pseudomonas aeruginosa infections].
Döring G
Infection; 1987; 15(1):47-50. PubMed ID: 3106228
[TBL] [Abstract][Full Text] [Related]
13. [Alginate, elastase and alkaline protease production of Pseudomonas aeruginosa strains isolated from various body sites].
Ciragil P; Söyletir G
Mikrobiyol Bul; 2004 Oct; 38(4):341-7. PubMed ID: 15700659
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa cystic fibrosis clinical isolates produce exotoxin A with altered ADP-ribosyltransferase activity and cytotoxicity.
Gallant CV; Raivio TL; Olson JC; Woods DE; Storey DG
Microbiology (Reading); 2000 Aug; 146 ( Pt 8)():1891-1899. PubMed ID: 10931893
[TBL] [Abstract][Full Text] [Related]
15. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM
JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125
[TBL] [Abstract][Full Text] [Related]
16. Positive correlation of algD transcription to lasB and lasA transcription by populations of Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.
Storey DG; Ujack EE; Mitchell I; Rabin HR
Infect Immun; 1997 Oct; 65(10):4061-7. PubMed ID: 9317008
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis.
Albus A; Saalmann M; Tesch H; Pedersen SS; Döring G
APMIS; 1989 Dec; 97(12):1146-8. PubMed ID: 2482060
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients.
Trancassini M; De Vito D; Quattrucci S; Cipriani P
New Microbiol; 1999 Apr; 22(2):85-9. PubMed ID: 10322606
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening.
Hayes D; Farrell PM; Li Z; West SE
Pediatr Pulmonol; 2010 Jan; 45(1):55-61. PubMed ID: 20025049
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal studies of virulence factors of Pseudomonas aeruginosa in cystic fibrosis.
Burke V; Robinson JO; Richardson CJ; Bundell CS
Pathology; 1991 Apr; 23(2):145-8. PubMed ID: 1745565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
